MedPath

A screening study of HER2 expression for biliary tract cancer

Not Applicable
Conditions
biliary tract cancer
Registration Number
JPRN-UMIN000036697
Lead Sponsor
ational Cancer Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HER2 expression
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath